We recently demonstrated the existence of an innate anti-glioma NK-mediated circuit initiated by glioma-released microRNA (miR-1983) within exosomes and which is under the regulation of Gal-1 (249). The gene discussed is LGALS1; the disease is central nervous system cancer.